Your location: Home > Program Outline
Program Details
2026-11-19
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
S101 Opening Remarks
(13:00 - 13:05) 		Session Ⅰ：Blueprinting the Standardized Management of RCC
(13:05 - 14:05) 		Session Ⅱ：Advancing the Frontier Diagnosis and Treatment of RCC
(14:05 - 15:05) 		Summary
(15:05 - 15:10) 		Opening Remarks
(16:00 - 16:15) 		Session 1
(16:15 - 16:40) 		Session 2
(16:40 - 17:20) 		Session 3-Discussion
(17:20 - 18:00)
S103 Part I: Opening Ceremony & Initial Data Presentation
(14:00 - 14:30) 		Part II: Mutual Learning in Research & Lectures, Concerted Support Along the Whole Journey
(14:30 - 16:20) 		Part III: Sino-foreign Integration, Evidence-based Conclusion
(16:20 - 18:10)
Opening Remarks
(14:00 - 14:30) 		Session 1: Exploring the Frontiers, Insights in Prostate Cancer
(14:30 - 15:30) 		Session 2: Digital-Intelligence Empowerment, Refined Quality Enhancement
(15:30 - 16:00) 		Session 3: Pursuit of Excellence, Expert Dialogue
(16:00 - 16:20) 		United in Effort for Two Years, Together We Open a New Chapter
(16:20 - 16:30) 		Session I: Global Vision, Embarking on a New Chapter
(16:30 - 17:00) 		Session 2: China Voice from CUA
(17:00 - 18:00)
Session 3 RWE in Review, Learning from the Past to Guide the Future
(17:50 - 18:20)
S105 Discovering Urological Frontiers
(13:35 - 15:35) 		Opening Remarks
(16:05 - 16:10) 		Session 1 - Invited Lectures
(16:10 - 16:55) 		Session 2 - Invited Lectures
(16:55 - 17:40) 		Session3- Invited Lectures
(17:40 - 18:05)
S107 Opening Remarks
(13:45 - 13:50) 		Chapter 1: Advancing Diagnosis and Treatment in Prostate Cancer
(13:50 - 14:45) 		Chapter 2: Insights into Knowledge and Practice-Prostate Cancer MDT
(14:45 - 15:45) 		Opening Remarks
(16:10 - 16:20) 		Session 1: From Consensus to Action: Shaping a New Era of High-Quality Development in GU in China
(16:20 - 16:45) 		Session 2: Advancing the Clinical Paradigm in RCC
(16:45 - 17:15) 		Roundtable Discussion
(17:15 - 17:30) 		Session 3: Advancing the Clinical Paradigm in PC
(17:30 - 17:45) 		Roundtable Discussion
(17:45 - 18:10)
S109 Opening Remarks
(13:30 - 13:40) 		Session 1 - Nurturing Talent, Shaping the Future
(13:40 - 14:45) 		Session2- Global Frontiers, Advancing Precision Care
(14:45 - 15:35) 		Summary
(15:35 - 15:40) 		Opening Remarks
(15:50 - 15:55) 		Session 1 -Molecular Testing
(15:55 - 17:05) 		Session 2-Molecular Imaging
(17:05 - 17:45) 		Summary
(17:45 - 17:50)
S111 Opening Remarks
(15:00 - 15:25) 		Advancing Care, Redefining Standards
(15:25 - 16:25) 		Beyond Survival, Leading the Future
(16:55 - 17:30) 		Discussion
(17:30 - 17:55) 		Summary
(17:55 - 18:00)
Discussion
(16:20 - 16:50)
S202 Part I: Innovation and Advancing Treatment Goals
(13:00 - 13:05) 		Scientific Presentation
(13:05 - 13:10) 		Symposium
(13:10 - 13:20) 		Expert Discussion
(13:20 - 13:30) 		Keynote Lecture
(13:30 - 13:45) 		Keynote Lecture
(13:45 - 14:00) 		Keynote Lecture
(14:00 - 14:15) 		Part II: Sound Practice and Long-Term Treatment Decisions (I)Session 1: Earlier Intervention and Key Perioperative Decisions
(14:15 - 14:55) 		Part II: Sound Practice and Long-Term Treatment Decisions (I)Session 2: Appropriate Intensification, Initial Decisions, and Long-Term Benefits in mHSPC
(14:55 - 15:35) 		Part II: Sound Practice and Long-Term Treatment Decisions (II)Session 3: Evidence for Precision Care, Stratification, and Sequencing in mCRPC
(15:35 - 16:15) 		Part II: Sound Practice and Long-Term Treatment Decisions (II)Session 4: Advanced Decision-Making and Comprehensive Care in Complex Clinical Scenarios
(16:15 - 16:50) 		Summary
(16:55 - 17:00)
V11 Opening Remarks
(13:20 - 13:30) 		Session 1: Oral Presentations 1
(13:30 - 14:00) 		Session 2:AI-Assisted Discussions on Challenging CasesUrological Engineering
(14:00 - 14:45) 		Session 2:AI-Assisted Discussions on Challenging CasesUrological Engineering-- Case Discussion 2
(14:45 - 15:25) 		Summary
(15:25 - 15:30) 		Opening
(15:30 - 15:40) 		Session1
(15:40 - 16:35) 		Session 2
(16:35 - 17:30)
V22 Opening Remarks
(13:40 - 14:00) 		Special Showcase of Signature Procedures for Single-Port Surgical Robots
(14:00 - 15:35) 		Summary
(15:35 - 15:40) 		Opening Remarks
(16:10 - 16:20)
(16:20 - 16:30)
(16:30 - 17:45)
(17:45 - 18:05) 		Summary
(18:05 - 18:10)
V23 Opening Remarks
(13:30 - 13:35) 		Session 1: Oral Presentations 1
(13:35 - 14:30) 		Session 2: Oral Presentations 2
(14:30 - 15:25) 		Summary
(15:25 - 15:30) 		Opening Remarks
(16:10 - 16:20) 		Session 1: First-Line Therapy for Renal Cell Carcinoma: Evidence-Based Discussion
(16:20 - 17:00) 		Session 2: First-Line Therapy for Renal Cell Carcinoma: Expert Exchange and Debate
(17:00 - 18:00) 		Summary
(18:00 - 18:10)
V24 Opening Remarks
(12:00 - 12:10) 		Session 1: Oral Presentations 1
(12:10 - 12:50) 		Summary
(12:50 - 13:05) 		Benign Urological Diseases：Opening Remarks
(16:00 - 16:05) 		Session 1: Evidence-led Advance
(16:05 - 17:05) 		Session 2: Paving the Way to the Future
(17:05 - 18:05)
V25 Opening Remarks
(13:45 - 13:55) 		Session 1: Oral Presentations 1
(13:55 - 15:40) 		Summary
(15:40 - 15:45)
InterContinental Ballroom 1
(13:30 - 13:40)
(13:40 - 14:10)
(14:10 - 14:55)
(14:55 - 15:30)
2026-11-20
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
5th‑Floor Grand Ballroom Opening Ceremony
(08:05 - 09:10) 		Keynote Speech
(09:10 - 10:05) 		International Lecture
(10:05 - 11:05) 		Special Topic Academic Report
(11:05 - 12:05) 		New Clinical Explorations
(12:05 - 13:00) 		New research breakthrough
(13:00 - 13:55) 		AI New Diagnosis and Treatment
(13:55 - 14:50) 		New treatment options
(14:50 - 15:45) 		New Management Paradigm
(15:45 - 16:40) 		Cutting-edge new therapy
(16:40 - 17:25)
2026-11-21
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
S102 Opening Remarks
(08:00 - 08:15) 		Oral Presentation 1
(08:15 - 09:30) 		Oral Presentation 2
(09:30 - 10:40) 		Oral Presentation 3
(10:40 - 12:00) 		Enterprise Special Meeting
(12:00 - 13:30) 		Opening Remarks
(13:30 - 13:40) 		Oral Presentation 4
(13:40 - 14:36) 		Oral Presentation 5
(14:36 - 15:32) 		Oral Presentation 6
(15:32 - 16:28) 		Oral Presentation 4
(16:28 - 17:16) 		Oral Presentation 8
(17:16 - 18:12) 		Summary
(18:12 - 18:17)
S105 Opening Remarks
(08:00 - 08:05) 		Session 1: Invited Lectures 1
(08:05 - 09:05) 		Session 2: Invited Lectures 2
(09:05 - 09:53) 		Session 3 Oral Presentations 1
(09:53 - 10:33) 		Session 4 Oral Presentations 2
(10:33 - 11:13) 		Session 5 Oral Presentations 3
(11:13 - 12:03) 		Summary
(12:03 - 12:10) 		1
(13:00 - 13:30) 		Opening Remarks
(13:30 - 13:35) 		Session 1 Special Lectures
(13:35 - 14:35) 		Session 2 Oral Presentations 1
(14:35 - 15:19) 		Session 3 Oral Presentations 2
(15:19 - 16:03) 		Session 4 Oral Presentations 3
(16:03 - 16:47) 		Session 5 Oral Presentations 4
(16:47 - 17:31) 		Session 6 Oral Presentations 5
(17:31 - 18:15) 		Summary
(18:15 - 18:20)
S106 Opening Remarks
(08:00 - 08:10) 		Section 1: Mechanisms of Urosepsis and Severe Urinary Tract Infection
(08:10 - 09:05) 		Section 2: Etiology and Drug Resistance Profiles of Urinary Tract Infection, and Risk Factors for Postoperative Infection
(09:05 - 10:00) 		Section 3: Diagnosis, Treatment, and Pharmacological Intervention Techniques for Urinary Tract Infection-Related Diseases
(10:00 - 10:55) 		Section 4: Advances in the Diagnosis and Treatment of Refractory Urinary Tract Infection and Complication Management
(10:55 - 11:50) 		Section 5: Summary
(11:50 - 12:05) 		Opening Remarks
(13:30 - 13:50) 		Session 1 - Surgical Techniques in Kidney Transplantation
(13:50 - 14:42) 		Session 2 - Infection and Rejection
(14:42 - 15:26) 		Session 3 - Management of Comorbidities in Kidney Transplant Recipients
(15:26 - 16:10) 		Session 4 - Basic Research and Transplant Nursing
(16:10 - 17:10) 		Meeting Summary
(17:10 - 17:20)
S107 Opening Remarks
(08:00 - 08:15) 		Section 1 Oral Presentations – Neurogenic Bladder & Neuromodulation
(08:15 - 10:02) 		Section 2 Oral Presentations – Prostate Disease & Male Lower Urinary Tract Symptoms
(10:02 - 12:10) 		Thematic Session
(13:15 - 13:30) 		Section 3 Oral Presentations – Female Pelvic Floor Disorders, Urinary Incontinence & Pelvic Organ Prolapse
(13:30 - 15:04) 		Section 4 Oral Presentations – Bladder Diseases
(15:04 - 16:02) 		Section 5 Oral Presentations – New Technologies & Equipment, Complex Cases
(16:02 - 17:16) 		Summary
(17:16 - 17:26)
S109 Opening Remarks
(08:00 - 08:10) 		Session 1: Surgical Innovation and Exploration of New Approaches
(08:10 - 09:20) 		Session 2: Functional Preservation and Precise Reconstruction
(09:20 - 10:30) 		Session 3: Intelligent Innovation for Precision Surgery
(10:30 - 11:30) 		Session 4: Complex Scenarios and Strategy Optimization
(11:30 - 12:30) 		Thematic Meeting
(13:05 - 13:20) 		Session 5: Innovation and Technical Advancement
(13:20 - 14:40) 		Session 6: Precision Renal Surgery and Functional Preservation
(14:40 - 15:50) 		Session 7: Challenging Cases and Advances in Complex Surgical Techniques
(15:50 - 16:50) 		Session 8: Reconstructive Surgery and Functional Management
(16:50 - 17:50) 		Robotics Session Summary
(17:50 - 17:55)
S110 Opening Remarks
(08:00 - 08:10) 		Session 1: Advances in Laser Surgery for the Prostate
(08:10 - 09:16) 		Session 2: Advances in Laser Lithotripsy
(09:16 - 10:22) 		Session 3: Laser Applications in Urological Oncology
(10:22 - 11:28) 		Session 4: Expanding Laser Urology — A Video Showcase of Diagnosis and Treatment in County-Level Hospitals
(11:28 - 11:55) 		Summary
(11:55 - 12:00) 		Opening Remarks
(13:30 - 13:55) 		Section 1 Innovative Urological Techniques and Evidence-based Exploration
(13:55 - 14:55) 		Section 2 Medical-research Integration, Grassroots Urology Development
(14:55 - 16:00) 		Section 3 Imaging Modeling, Intelligent Exploration of Urology
(16:00 - 17:00) 		Section 4 Surgical Technique Research and Clinical Problem Solving
(17:00 - 17:50) 		Summary
(17:50 - 18:00)
S111 Opening Remarks
(08:00 - 08:10) 		Section 1: Robotic Surgery Session 1
(08:10 - 09:10) 		Section 2: Robotic Surgery Session 2
(09:10 - 10:10) 		Section 3: Single-Port Robotic Surgery
(10:10 - 11:00) 		Section 4: Laparoscopic Surgery Session 1
(11:00 - 11:50) 		Section 5: Laparoscopic Surgery Session 2
(11:50 - 12:30) 		Section 6: Stones and Endoscopy
(12:30 - 13:40) 		Section 7: AI and Intraoperative Navigation
(13:40 - 14:40) 		Section 8: Transurethral Surgery
(14:40 - 15:40) 		Section 9: Ablation and Complication Management
(15:40 - 16:56) 		Summary
(16:56 - 17:00)
S201 Opening Remarks
(08:00 - 08:20) 		Session 1 Oral Presentations 1
(08:20 - 09:40) 		Session 2 Oral Presentations2
(09:40 - 11:00) 		Session 3 Oral Presentations 3
(11:00 - 12:20) 		Opening Remarks
(13:30 - 13:40) 		Session 1 Oral Presentations 4
(13:40 - 15:00) 		Session 2 Oral Presentations 5
(15:10 - 16:35) 		Session 3 Oral Presentations 6
(16:40 - 18:00) 		Summary
(18:00 - 18:10)
S202 Opening Remarks
(08:00 - 08:20) 		Session 1 Oral Presentation 1
(08:20 - 09:30) 		Session 2 Oral Presentations 2
(09:30 - 10:40) 		Session 3 Oral Presentations 3
(10:40 - 11:50) 		Thematic Session1
(12:30 - 12:45) 		Thematic Session2
(12:45 - 13:00) 		Thematic Session3
(13:00 - 13:15) 		Thematic Session4
(13:15 - 13:30) 		Opening Remarks
(13:30 - 13:40) 		Session 4 Oral Presentations 4
(13:40 - 14:40) 		Session 5 Oral Presentations 5
(14:40 - 15:40) 		Coffee break
(15:40 - 15:50) 		Session 6 Oral Presentations 6
(15:50 - 16:50) 		Session 7 Oral Presentations 7
(16:50 - 17:50) 		Closing Remarks
(17:50 - 18:00)
S203 Opening Remarks
(08:00 - 08:10) 		Session 1: Themed Lecture 1
(08:10 - 09:55) 		Session 2: Themed Lecture 2
(09:55 - 11:40) 		Session 3: Clinical Research Insider
(11:40 - 12:30) 		Thematic Meeting
(12:30 - 13:30) 		Session 4: Precision treatment frontiers
(13:30 - 14:30) 		Session 5: Precision diagnosis frontiers
(14:30 - 15:30) 		Session 6: Multi-center prospective study
(15:30 - 16:30) 		Session 7: Single-center prospective study
(16:30 - 17:30) 		Session 8: Retrospective study
(17:30 - 18:36) 		Summary
(18:36 - 18:40)
S204 Opening Remarks
(08:00 - 08:10) 		Session 1 Oral Presentations 1
(08:10 - 09:20) 		Session 2 Oral Presentations 2
(09:20 - 10:30) 		Session 3 Oral Presentations 3
(10:30 - 11:33) 		Session 4 Oral Presentations 4
(11:33 - 12:36) 		Opening Remarks
(13:20 - 13:30) 		Session 1 Oral Presentations 1
(13:30 - 14:40) 		Session 2 Oral Presentations 2
(14:40 - 15:50) 		Session 3 Oral Presentations 3
(15:50 - 17:20)
S205 Opening Remarks
(08:00 - 08:10) 		Group Photo
(08:10 - 08:15) 		Session 1 — Rebirth in Urology: Striving for Excellence
(08:15 - 09:15) 		Session 2 — Frontiers in Specialty Nursing: Collaborative Care
(09:15 - 10:00) 		Session 3 — Pelvic Floor Reconstruction: Continence Restoration (Precision Nursing for Voiding Dysfunction)
(10:00 - 10:45) 		Session 4 — Treating Both Body and Mind: Holistic Care Throughout the Continuum
(10:45 - 11:30) 		Session 5 — Reshaping Life: Return to Society (Illness Perception, Financial Toxicity, and Life-Course Care)
(11:30 - 12:15) 		Thematic Meeting
(12:15 - 13:15) 		Session 6 — Popular Science Empowerment: Mutual Growth in Teaching and Learning
(13:15 - 13:55) 		Session 8 — Quality First: Safeguarding Safety
(14:37 - 15:25) 		Session 9 — Difficult and Critical Cases : Case Analysis
(15:25 - 16:16)
Session 7 — Humanistic Care: Intelligent Nursing for Body and Mind
(13:52 - 14:37) 		Session 10 — Digital Intelligence Empowerment: Optimizing the Full Course of Nursing
(16:15 - 17:15)
S206 Opening Remarks
(07:50 - 08:45)
(08:45 - 09:21) 		Session 2 Upper Urinary Tract Disorders
(09:22 - 09:46) 		Session 3 Lower Urinary Tract and Continence Disorders
(09:47 - 10:11) 		Session 4 Pediatric Urolithiasis I
(10:12 - 10:30) 		Session 5 Pediatric Urolithiasis II
(10:31 - 10:46) 		Session 6 Tumors and Basic Research
(10:47 - 11:08) 		Session 7 Robotic Surgery
(11:08 - 11:23) 		Session 8 New Technologies in Pediatric Urology
(11:24 - 11:42) 		Session 9 Pediatric Andrology and Urethral Reconstruction
(11:43 - 12:19) 		Session 10 Pediatric Urology Nursing
(12:20 - 12:32) 		Summary
(12:32 - 12:35) 		Opening Remarks
(13:00 - 13:15) 		Section 1 – Global Perspectives: International Experts on Urological tumor Imaging and Remote Surgery
(13:15 - 14:10) 		Section 2 – Intelligence in Urology: Artificial Intelligence Empowering Clinical Diagnosis and Treatment
(14:10 - 15:05) 		Section 3 - Discriminating Tumors with Insight: AI-Driven Precision Therapy and Risk Assessment for Urological Tumors
(15:05 - 16:00) 		Section 4 - Data Aggregation and Model Initiation: Construction of a Multi-center, Multi-modal Data and Intelligent Model System
(16:00 - 17:05) 		Section 5 - Wisdom Expands Yellow Emperor’s Medicine: Artificial Intelligence Empowers Urology — Cutting-edge Progress and Domestic Practice Exploration
(17:05 - 18:10)
S207 Opening Remarks
(13:30 - 13:40) 		Session 1: Oral Presentations 1
(13:40 - 14:48) 		Session 2: Oral Presentations 2
(14:48 - 15:56) 		Session 3: Oral Presentations 3
(15:56 - 17:04) 		Summary
(17:04 - 17:10)